BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15741793)

  • 1. Medication patterns in patients with autism: temporal, regional, and demographic influences.
    Aman MG; Lam KS; Van Bourgondien ME
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):116-26. PubMed ID: 15741793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina.
    Langworthy-Lam KS; Aman MG; Van Bourgondien ME
    J Child Adolesc Psychopharmacol; 2002; 12(4):311-21. PubMed ID: 12625991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.
    Aman MG; Lam KS; Collier-Crespin A
    J Autism Dev Disord; 2003 Oct; 33(5):527-34. PubMed ID: 14594332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
    Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment incidence and patterns in children and adolescents with autism spectrum disorders.
    Witwer A; Lecavalier L
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):671-81. PubMed ID: 16190798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R; Jariwala K; West-Strum D
    J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
    Hong M; Lee SY; Han J; Park JC; Lee YJ; Hwangbo R; Chang H; Cho SW; Bhang SY; Kim B; Hwang JW; Bahn GH
    J Korean Med Sci; 2017 Oct; 32(10):1687-1693. PubMed ID: 28875615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication use among children with autism spectrum disorders.
    Oswald DP; Sonenklar NA
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):348-55. PubMed ID: 17630868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?
    Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP
    Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder.
    Gerhard T; Chavez B; Olfson M; Crystal S
    J Clin Psychopharmacol; 2009 Jun; 29(3):307-10. PubMed ID: 19440093
    [No Abstract]   [Full Text] [Related]  

  • 12. Should clinical trial research of psychotropic medication in autism control for gastrointestinal symptoms?
    Heitzer AM; Job MA; Pandit NK; Valdovinos MG
    J Clin Pharmacol; 2014 Oct; 54(10):1093-6. PubMed ID: 24788353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The administration of psychotropic medication to children ages 0-4 in North Carolina: an exploratory analysis.
    Ellis AR
    N C Med J; 2010; 71(1):9-14. PubMed ID: 20369666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.
    Esbensen AJ; Greenberg JS; Seltzer MM; Aman MG
    J Autism Dev Disord; 2009 Sep; 39(9):1339-49. PubMed ID: 19434487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency medical services use by the elderly: analysis of a statewide database.
    Platts-Mills TF; Leacock B; Cabañas JG; Shofer FS; McLean SA
    Prehosp Emerg Care; 2010; 14(3):329-33. PubMed ID: 20507220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects associated with psychoactive medication in individuals with autism.
    Aman MG; Van Bourgondien ME; Osborne PW; Sarphare G
    J Autism Dev Disord; 1997 Jun; 27(3):342-4. PubMed ID: 9229265
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychotropic Medication Prescribing for Youth at a Regional Autism Center.
    Gannon S; Abdelrazek A; Keller K; Rockhill C; Kim SJ
    J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):653-658. PubMed ID: 34242065
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.